June 30, 2025

Breakthrough Device Approvals Outpacing Data

Many FDA-authorized breakthrough therapeutic devices may lack robust clinical testing.

Conexiant

June 27, 2025

Ecnoglutide Shows Strong Weight Loss in Trial

A once-weekly GLP-1 receptor agonist, ecnoglutide, led to significant and sustained weight loss in a large study of adults with overweight or obesity, with favorable safety outcomes reported at the ADA’s 85th Scientific Sessions.

Conexiant

June 27, 2025

Once-Monthly Drug Cuts Weight by 16%: Study

A once-monthly injectable GLP-1/GIP modulator demonstrated substantial weight loss in adults with obesity, with or without type 2 diabetes.

Conexiant

June 25, 2025

Top Physical Therapies for Knee OA

A large-scale analysis of physical therapies for knee osteoarthritis found knee bracing, hydrotherapy, and exercise to be the most effective options for reducing pain and improving function.

Conexiant

June 24, 2025

Dermatologists Show Lowest Turnover Intent of All Specialists

AMA data show only 19.9% of dermatologists plan to leave their current positions, compared with 40.6% of anesthesiologists.

Conexiant

June 23, 2025

Is OLIF the Better Back Bet?

A study comparing two spine surgeries in older adults found that OLIF significantly reduced hospital stays, complications, and improved back structure compared with TLIF.

Conexiant

June 23, 2025

Chronic Pain Persists After Joint Replacement Surgery

Roughly 1 in 5 knee replacement patients still experience joint pain after three months, according to a large analysis of nearly 600,000 surgeries.

Conexiant

June 23, 2025

Teen ACL Injuries Linked to High Reinjury Risk

A long-term study of adolescent athletes who underwent ACL reconstruction found high rates of reinjury and other knee damage but also noted that most returned to sports and reported improved knee function over time.

Conexiant

June 19, 2025

Is More Fiber the Heart’s Ally?

A long-term U.S. study found that greater adherence to a plant-based cholesterol-lowering diet was linked to lower cardiovascular, coronary heart disease, and all-cause mortality.

Conexiant